Display options
Cite
Reinke S, Thakur A, Gartlan C, et al. Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines (Basel). 2020;8(3)doi: 10.3390/vaccines8030554.
Reinke, S., Thakur, A., Gartlan, C., Bezbradica, J. S., & Milicic, A. (2020). Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines, 8(3), . https://doi.org/10.3390/vaccines8030554
Reinke, Sören, et al. "Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants." Vaccines vol. 8,3 (2020). doi: https://doi.org/10.3390/vaccines8030554
Reinke S, Thakur A, Gartlan C, Bezbradica JS, Milicic A. Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines (Basel). 2020 Sep 22;8(3). doi: 10.3390/vaccines8030554. PMID: 32971761; PMCID: PMC7565252.
Copy Download .nbib Format: NLM
Share it on

Vaccines (Basel). 2020 Sep 22;8(3). doi: 10.3390/vaccines8030554.

Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.

Vaccines

Sören Reinke, Aneesh Thakur, Cillian Gartlan, Jelena S Bezbradica, Anita Milicic

Affiliations

  1. The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  2. Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark.
  3. Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin D02 R590, Ireland.
  4. Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK.

PMID: 32971761 PMCID: PMC7565252 DOI: 10.3390/vaccines8030554

Abstract

In modern vaccines, adjuvants can be sophisticated immunological tools to promote robust and long-lasting protection against prevalent diseases. However, there is an urgent need to improve immunogenicity of vaccines in order to protect mankind from life-threatening diseases such as AIDS, malaria or, most recently, COVID-19. Therefore, it is important to understand the cellular and molecular mechanisms of action of vaccine adjuvants, which generally trigger the innate immune system to enhance signal transition to adaptive immunity, resulting in pathogen-specific protection. Thus, improved understanding of vaccine adjuvant mechanisms may aid in the design of "intelligent" vaccines to provide robust protection from pathogens. Various commonly used clinical adjuvants, such as aluminium salts, saponins or emulsions, have been identified as activators of inflammasomes - multiprotein signalling platforms that drive activation of inflammatory caspases, resulting in secretion of pro-inflammatory cytokines of the IL-1 family. Importantly, these cytokines affect the cellular and humoral arms of adaptive immunity, which indicates that inflammasomes represent a valuable target of vaccine adjuvants. In this review, we highlight the impact of different inflammasomes on vaccine adjuvant-induced immune responses regarding their mechanisms and immunogenicity. In this context, we focus on clinically relevant adjuvants that have been shown to activate the NLRP3 inflammasome and also present various experimental adjuvants that activate the NLRP3-, NLRC4-, AIM2-, pyrin-, or non-canonical inflammasomes and could have the potential to improve future vaccines. Together, we provide a comprehensive overview on vaccine adjuvants that are known, or suggested, to promote immunogenicity through inflammasome-mediated signalling.

Keywords: AIM2; NLRC4; NLRP3; adjuvant; caspase-1; immunogenicity; inflammasome; non-canonical; pyrin; vaccine

References

  1. Science. 2018 Nov 23;362(6417):956-960 - PubMed
  2. PLoS One. 2013 Jun 13;8(6):e65964 - PubMed
  3. Vaccines (Basel). 2015 Apr 16;3(2):320-43 - PubMed
  4. Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10501-6 - PubMed
  5. Immunity. 2015 Jul 21;43(1):146-60 - PubMed
  6. Nature. 1984 Mar 29-Apr 4;308(5958):457-60 - PubMed
  7. Immunity. 2006 Feb;24(2):179-89 - PubMed
  8. Nat Immunol. 2019 May;20(5):527-533 - PubMed
  9. Nat Immunol. 2008 Aug;9(8):847-56 - PubMed
  10. Expert Rev Vaccines. 2017 Sep;16(9):895-906 - PubMed
  11. Phytomedicine. 2019 Jul;60:152905 - PubMed
  12. Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13463-8 - PubMed
  13. Sci Rep. 2015 Nov 25;5:16719 - PubMed
  14. Expert Rev Vaccines. 2003 Apr;2(2):197-203 - PubMed
  15. J Mol Biol. 2018 Jan 19;430(2):217-237 - PubMed
  16. Science. 2016 Jun 3;352(6290):1232-6 - PubMed
  17. Vaccine. 2001 Mar 21;19(17-19):2666-72 - PubMed
  18. Cell Metab. 2017 Jul 5;26(1):71-93 - PubMed
  19. J Immunol. 2011 Feb 15;186(4):2495-502 - PubMed
  20. Semin Immunol. 2018 Oct;39:14-21 - PubMed
  21. Vaccine. 2006 Aug 14;24(33-34):5937-49 - PubMed
  22. Eur J Immunol. 2018 Feb;48(2):230-238 - PubMed
  23. PLoS One. 2012;7(7):e38553 - PubMed
  24. Nature. 1998 Mar 19;392(6673):245-52 - PubMed
  25. ACS Nano. 2014 Aug 26;8(8):7723-32 - PubMed
  26. J Immunol. 2011 Feb 15;186(4):2584-91 - PubMed
  27. Immunity. 2013 Dec 12;39(6):1003-18 - PubMed
  28. Vaccine. 2012 Mar 30;30(16):2689-96 - PubMed
  29. J Biol Chem. 2016 Jan 15;291(3):1123-36 - PubMed
  30. Vaccine. 2013 Jan 11;31(4):653-60 - PubMed
  31. Trends Pharmacol Sci. 2017 Sep;38(9):771-793 - PubMed
  32. Expert Rev Vaccines. 2013 Jul;12(7):809-19 - PubMed
  33. Vaccine. 2013 Jul 18;31(33):3363-9 - PubMed
  34. Immunity. 2008 Nov 14;29(5):807-18 - PubMed
  35. J Exp Med. 2009 Jan 16;206(1):89-97 - PubMed
  36. Infect Immun. 2005 Oct;73(10):6763-70 - PubMed
  37. Nat Immunol. 2007 Sep;8(9):950-7 - PubMed
  38. J Cell Biol. 2016 Jun 20;213(6):617-29 - PubMed
  39. Front Immunol. 2017 Dec 13;8:1760 - PubMed
  40. NPJ Vaccines. 2017 Sep 8;2:25 - PubMed
  41. Cell Rep. 2018 Aug 7;24(6):1425-1433 - PubMed
  42. Nat Med. 2011 Apr;17(4):479-87 - PubMed
  43. J Immunol. 2015 Apr 15;194(8):3829-39 - PubMed
  44. Semin Immunol. 2013 Apr;25(2):130-45 - PubMed
  45. Eur J Immunol. 2015 Oct;45(10):2911-7 - PubMed
  46. J Immunol. 2019 Sep 15;203(6):1457-1467 - PubMed
  47. Eur J Immunol. 2015 Feb;45(2):407-17 - PubMed
  48. Science. 2013 Sep 13;341(6151):1246-9 - PubMed
  49. Adv Healthc Mater. 2014 Aug;3(8):1194-9 - PubMed
  50. J Drug Target. 2018 Jun - Jul;26(5-6):474-480 - PubMed
  51. Vaccine. 2015 Jan 3;33(2):298-306 - PubMed
  52. Nature. 2018 Dec;564(7734):71-76 - PubMed
  53. Clin Diagn Lab Immunol. 2000 Nov;7(6):899-903 - PubMed
  54. Nature. 1995 Nov 2;378(6552):88-91 - PubMed
  55. Nat Immunol. 2015 Apr;16(4):354-65 - PubMed
  56. Hum Vaccin Immunother. 2017 Jan 2;13(1):19-33 - PubMed
  57. J Biol Chem. 2002 Oct 25;277(43):41282-6 - PubMed
  58. Cell Mol Life Sci. 2009 Jan;66(1):43-61 - PubMed
  59. Nat Immunol. 2015 Apr;16(4):343-53 - PubMed
  60. Eur J Immunol. 2015 Oct;45(10):2927-36 - PubMed
  61. Cell Rep. 2020 Feb 25;30(8):2501-2511.e5 - PubMed
  62. Int J Pharm. 2018 Dec 1;552(1-2):7-15 - PubMed
  63. J Exp Med. 1998 Oct 19;188(8):1485-92 - PubMed
  64. J Immunol. 2008 Jul 1;181(1):17-21 - PubMed
  65. J Immunol. 2011 Jul 1;187(1):55-63 - PubMed
  66. Vaccine. 2009 Jun 19;27(30):3984-91 - PubMed
  67. J Exp Med. 1994 Oct 1;180(4):1263-72 - PubMed
  68. Annu Rev Med. 2014;65:223-44 - PubMed
  69. PLoS One. 2013;8(1):e53531 - PubMed
  70. Rev Immunol Ther Antimicrob. 1964 Jan-Mar;28:49-62 - PubMed
  71. Eur J Immunol. 2010 Dec;40(12):3528-34 - PubMed
  72. Drug Discov Ther. 2015 Apr;9(2):88-93 - PubMed
  73. J Immunol. 2008 Sep 15;181(6):3755-9 - PubMed
  74. J Immunol. 2007 Aug 1;179(3):1423-6 - PubMed
  75. Immunity. 2013 Jun 27;38(6):1142-53 - PubMed
  76. Front Immunol. 2018 Jan 24;8:1988 - PubMed
  77. J Immunol. 2010 Mar 15;184(6):2756-60 - PubMed
  78. Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7119-24 - PubMed
  79. Vaccine. 2003 Jun 2;21(19-20):2461-7 - PubMed
  80. Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21095-100 - PubMed
  81. J Exp Med. 1997 Dec 1;186(11):1819-29 - PubMed
  82. Vaccines (Basel). 2015 Jul 24;3(3):579-96 - PubMed
  83. Hum Vaccin Immunother. 2018 Jan 2;14(1):17-27 - PubMed
  84. Expert Rev Vaccines. 2018 Apr;17(4):335-349 - PubMed
  85. PLoS One. 2016 May 05;11(5):e0154757 - PubMed
  86. Nat Rev Immunol. 2013 Aug;13(8):592-605 - PubMed
  87. Immunity. 2018 Jan 16;48(1):35-44.e6 - PubMed
  88. J Immunol. 2014 Feb 15;192(4):1587-96 - PubMed
  89. Nature. 2008 Jun 19;453(7198):1122-6 - PubMed
  90. Biochim Biophys Acta. 2005 Dec 10;1718(1-2):22-31 - PubMed
  91. Nat Med. 2011 Jul 17;17(8):996-1002 - PubMed
  92. Inflammation. 2020 Dec;43(6):2301-2311 - PubMed
  93. Hum Vaccin Immunother. 2016 Oct 2;12(10):2709-2711 - PubMed
  94. Vaccine. 2011 Aug 26;29(37):6313-20 - PubMed
  95. Bioconjug Chem. 2012 Aug 15;23(8):1513-23 - PubMed
  96. Clin Vaccine Immunol. 2010 Dec;17(12):1952-7 - PubMed
  97. Expert Rev Vaccines. 2002 Jun;1(1):111-8 - PubMed
  98. Front Immunol. 2013 May 16;4:114 - PubMed
  99. Nat Commun. 2016 Nov 07;7:13324 - PubMed
  100. J Immunol. 1997 Sep 1;159(5):2125-31 - PubMed
  101. Immunol Cell Biol. 2014 Jul;92(6):535-42 - PubMed
  102. Int J Mol Sci. 2018 Nov 15;19(11): - PubMed
  103. Cell Rep. 2018 Mar 6;22(10):2642-2653 - PubMed
  104. J Immunol. 2018 Jul 1;201(1):98-112 - PubMed
  105. Clin Diagn Lab Immunol. 2002 Sep;9(5):1021-4 - PubMed
  106. Eur J Immunol. 2012 Sep;42(9):2215-20 - PubMed
  107. Front Immunol. 2017 Jan 05;7:663 - PubMed
  108. Science. 2007 Jun 15;316(5831):1628-32 - PubMed
  109. Infect Immun. 2015 Jun;83(6):2496-506 - PubMed
  110. J Immunol. 1998 Oct 1;161(7):3400-7 - PubMed
  111. J Immunol. 2009 Nov 15;183(10):6186-97 - PubMed
  112. J Cell Biol. 1986 Sep;103(3):699-709 - PubMed
  113. Hum Vaccin. 2008 May-Jun;4(3):246-50 - PubMed
  114. J Immunol. 2008 Aug 1;181(3):1627-31 - PubMed
  115. Expert Rev Vaccines. 2011 Dec;10(12):1731-42 - PubMed
  116. Eur J Immunol. 2008 Aug;38(8):2085-9 - PubMed
  117. ACS Nano. 2013 May 28;7(5):3926-38 - PubMed
  118. Int Rev Immunol. 2013 Apr;32(2):209-20 - PubMed
  119. J Immunol. 2012 Nov 1;189(9):4331-7 - PubMed
  120. Curr Top Microbiol Immunol. 2015;386:151-80 - PubMed
  121. Vaccine. 2013 Jun 26;31(30):3051-8 - PubMed
  122. Immunobiology. 2013 Apr;218(4):664-73 - PubMed
  123. J Immunol. 2009 Oct 1;183(7):4403-14 - PubMed
  124. Eur J Immunol. 2015 Oct;45(10):2918-26 - PubMed
  125. Semin Immunopathol. 2015 Jul;37(4):419-27 - PubMed
  126. Immunity. 2016 Mar 15;44(3):597-608 - PubMed
  127. J Immunol. 2012 Dec 15;189(12):5508-12 - PubMed
  128. Vaccine. 2016 Jan 12;34(3):306-12 - PubMed
  129. Vaccine. 2014 Nov 12;32(48):6377-89 - PubMed
  130. Science. 2012 Feb 24;335(6071):984-9 - PubMed
  131. NPJ Vaccines. 2019 Jan 3;4:1 - PubMed
  132. Front Cell Infect Microbiol. 2017 Jun 08;7:247 - PubMed
  133. FEBS J. 2018 Jul;285(13):2377-2401 - PubMed
  134. Front Immunol. 2019 Jun 11;10:1291 - PubMed
  135. Eur J Immunol. 2000 Apr;30(4):1113-9 - PubMed
  136. Vaccine. 2011 Jul 18;29(32):5145-52 - PubMed
  137. Mol Cell. 2002 Aug;10(2):417-26 - PubMed
  138. Part Fibre Toxicol. 2013 Feb 12;10:3 - PubMed
  139. Vaccines (Basel). 2013 Sep 25;1(4):415-43 - PubMed
  140. J Immunol. 2006 Jan 15;176(2):1203-8 - PubMed
  141. Vaccine. 2016 Feb 24;34(9):1162-71 - PubMed
  142. J Immunol. 2006 Jun 15;176(12):7278-87 - PubMed
  143. J Immunol. 2009 Jul 15;183(2):787-91 - PubMed
  144. J Exp Med. 2009 Dec 21;206(13):2879-88 - PubMed
  145. J Immunol. 2015 Jan 15;194(2):630-6 - PubMed
  146. Nat Med. 2013 Dec;19(12):1597-608 - PubMed
  147. Expert Rev Vaccines. 2012 Mar;11(3):349-66 - PubMed
  148. Nat Immunol. 2010 Nov;11(11):1014-22 - PubMed
  149. Nature. 2011 Oct 16;479(7371):117-21 - PubMed
  150. Int Immunol. 2019 Sep 18;31(10):657-668 - PubMed
  151. Nat Rev Immunol. 2013 Jun;13(6):397-411 - PubMed
  152. Nat Rev Microbiol. 2007 Jul;5(7):505-17 - PubMed
  153. ACS Appl Mater Interfaces. 2017 Jul 5;9(26):21697-21705 - PubMed
  154. Eur J Immunol. 2000 Nov;30(11):3147-56 - PubMed
  155. Vaccine. 2011 Mar 16;29(13):2461-73 - PubMed
  156. Nat Immunol. 2007 Sep;8(9):942-9 - PubMed
  157. PLoS One. 2014 Mar 28;9(3):e92634 - PubMed
  158. Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11169-74 - PubMed
  159. J Immunol. 2014 Apr 1;192(7):3259-68 - PubMed
  160. Mol Cancer Ther. 2019 Feb;18(2):323-334 - PubMed
  161. Front Pediatr. 2018 Nov 09;6:321 - PubMed
  162. J Biol Chem. 2011 Jun 17;286(24):21137-44 - PubMed
  163. Eur J Immunol. 2012 Oct;42(10):2709-19 - PubMed
  164. Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2497-502 - PubMed
  165. J Immune Based Ther Vaccines. 2008 Aug 12;6:4 - PubMed
  166. Immunity. 2011 Apr 22;34(4):514-26 - PubMed
  167. Vaccine. 2012 Aug 24;30(39):5761-9 - PubMed
  168. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2927-32 - PubMed
  169. J Immunol. 1990 Nov 15;145(10):3340-7 - PubMed
  170. Clin Immunol. 2016 Aug;169:16-27 - PubMed
  171. Immunity. 2017 Oct 17;47(4):697-709.e3 - PubMed
  172. Nature. 1997 Aug 21;388(6644):782-7 - PubMed
  173. Expert Rev Vaccines. 2015 Mar;14(3):447-59 - PubMed
  174. Sci Rep. 2018 Sep 11;8(1):13582 - PubMed
  175. Nat Rev Immunol. 2017 Mar;17(3):208-214 - PubMed
  176. Nat Rev Immunol. 2016 Jul;16(7):407-20 - PubMed
  177. Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):870-5 - PubMed
  178. J Immunol. 2014 Jun 15;192(12):5943-51 - PubMed
  179. J Exp Med. 2013 Mar 11;210(3):491-502 - PubMed
  180. Immunol Rev. 2018 Jan;281(1):99-114 - PubMed
  181. Arch Biochem Biophys. 2019 Jul 30;670:4-14 - PubMed
  182. Nature. 1997 Aug 21;388(6644):787-92 - PubMed
  183. Sci Rep. 2016 Dec 20;6:39475 - PubMed
  184. AIDS. 2005 Sep 23;19(14):1473-9 - PubMed

Publication Types

Grant support